HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

One of the most sought-after vaccines in medicine is the HIV vaccine. When HIV was first discovered in 1981, scientists were optimistic that they would be able to develop a vaccine in a few years.

The project, aptly named BRILLIANT, an acronym for “Bringing Innovation to Clinical and Laboratory Research to End HIV in ...

Human CMV gene blocks necessary T cell response; HIV vaccines engineered without the gene being tested in clinical trials ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans. The study, ...

The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...

They found success in an unlikely source -- ... July 2, 2024 — A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast. Although a person initially becomes ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...